Larvol Delta - Adicet-Bio-to-Host-Investor-Webcast-to-Discuss-Updated-Clinical-Data-from-Ongoing-ADI001-Phase-1-Trial-in-Patients-with-Relapsed-or-Refractory-Aggressive-BCell-NonHodgkins-Lymphoma-NHL

ADI-001 - Adicet Bio

https://www.businesswire.com/news/home/20221201006019/en/Adicet-Bio-to-Host-Investor-Webcast-to-Discuss-Updated-Clinical-Data-from-Ongoing-ADI-001-Phase-1-Trial-in-Patients-with-Relapsed-or-Refractory-Aggressive-B-Cell-Non-Hodgkin%E2%80%99s-Lymphoma-NHL

Dec 2, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next